Earnings Feed
Start Free
|4Feb 18, 2:40 PM ET

Covelens Courtney Lee 4

4 · QNB CORP. · Filed Feb 18, 2026

Research Summary

AI-generated summary of this filing

Updated

QNB Corp (QNBC) EVP Courtney Covelens Receives Restricted Stock Award

What Happened

  • Courtney Covelens, EVP and Chief Retail Officer at QNB Corp (QNBC), was granted restricted stock awards on Feb 13, 2026. The grants total 1,500 shares at a reported price of $38.00 per share, with an aggregate value of approximately $57,000.
  • The filing shows one grant of 750 shares and three additional 250-share awards reported as derivative awards; all entries are labeled as acquisitions (awards), not open-market purchases or sales.

Key Details

  • Transaction date: 2026-02-13; Form 4 filed: 2026-02-18 (filed within the required two business days, timely).
  • Price reported: $38.00 per share for all awards.
  • Shares detailed in this filing: 750 shares (direct award) + 3 × 250 shares (derivative awards) = 1,500 shares; total value ≈ $57,000.
  • Footnote F1: Restricted Stock Award — the grants are restricted stock awards (typically subject to vesting and transfer restrictions).
  • Shares owned after the transaction: not specified in the provided summary of the filing.

Context

  • Restricted stock awards are normally subject to vesting schedules and holding restrictions, so these grants do not represent an immediate sale or market trade. They are routine compensation/retention awards and should not be interpreted as a direct buy/sell signal.
  • The filing indicates awards (code A); derivative entries mean the awards are structured as restricted/derivative shares rather than an exercised option or a gift.

Insider Transaction Report

Form 4
Period: 2026-02-13
QNB CORP.QNBC
Covelens Courtney Lee
EVP, Chief Retail Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-13$38.00/sh+750$28,500→ 3,984.297 total
  • Award

    Performance-based restricted stock award

    2026-02-13$38.00/sh+250$9,500→ 250 total
    Exercise: $0.00From: 2026-02-13Exp: 2036-02-13→ Common Stock (250 underlying)
  • Award

    Performance-based restricted stock award

    2026-02-13$38.00/sh+250$9,500→ 250 total
    Exercise: $0.00From: 2027-02-13Exp: 2036-02-13→ Common Stock (250 underlying)
  • Award

    Performance-based restricted stock award

    2026-02-13$38.00/sh+250$9,500→ 250 total
    Exercise: $0.00From: 2028-02-13Exp: 2036-02-13→ Common Stock (250 underlying)
Holdings

  • Common Stock(Right to Buy)

    Exercise: $37.26From: 2025-02-15Exp: 2027-02-15→ Common Stock (1,000 underlying)
    1,000

  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2024-02-15Exp: 2033-02-15→ Common Stock (700 underlying)
    700

  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2025-02-15Exp: 2033-02-15→ Common Stock (700 underlying)
    700

  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2026-02-15Exp: 2033-02-15→ Common Stock (700 underlying)
    700

  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2027-02-15Exp: 2033-02-15→ Common Stock (700 underlying)
    700

  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2028-02-15Exp: 2033-02-15→ Common Stock (700 underlying)
    700

  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2025-02-15Exp: 2034-02-15→ Common Stock (600 underlying)
    600

  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2026-02-15Exp: 2034-02-15→ Common Stock (600 underlying)
    600

  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2027-02-15Exp: 2034-02-15→ Common Stock (600 underlying)
    600

  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2028-02-15Exp: 2034-02-15→ Common Stock (600 underlying)
    600

  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2029-02-15Exp: 2034-02-15→ Common Stock (600 underlying)
    600

  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2026-02-14Exp: 2035-02-14→ Common Stock (860 underlying)
    860

  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2027-02-14Exp: 2035-02-14→ Common Stock (860 underlying)
    860

  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2028-02-14Exp: 2035-02-14→ Common Stock (860 underlying)
    860

  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2029-02-14Exp: 2035-02-14→ Common Stock (860 underlying)
    860

  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2030-02-14Exp: 2035-02-14→ Common Stock (860 underlying)
    860
Footnotes (1)
  • [F1]Restricted Stock Award
Signature
Courtney Covelens|2026-02-18

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT